Detalhe da pesquisa
1.
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.
Blood
; 141(4): 391-405, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126301
2.
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.
J Transl Med
; 22(1): 208, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413989
3.
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer.
J Transl Med
; 21(1): 635, 2023 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726810
4.
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins.
Haematologica
; 108(1): 219-233, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073514
5.
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma.
Molecules
; 28(3)2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36771100
6.
Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.
Int J Mol Sci
; 23(19)2022 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36232638
7.
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma.
Haematologica
; 106(1): 185-195, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079692
8.
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
Int J Mol Sci
; 22(19)2021 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34639154
9.
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
Int J Mol Sci
; 22(21)2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769070
10.
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92.
Blood
; 132(10): 1050-1063, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997223
11.
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
Blood
; 129(16): 2233-2245, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096095
12.
Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches.
Molecules
; 23(8)2018 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126100
13.
Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin.
J Cell Physiol
; 232(7): 1640-1649, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27607345
14.
Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
J Transl Med
; 14(1): 133, 2016 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27176720
15.
MYD88-independent growth and survival effects of Sp1 transactivation in Waldenstrom macroglobulinemia.
Blood
; 123(17): 2673-81, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24622324
16.
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
J Cell Physiol
; 229(12): 2106-16, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24819167
17.
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
Blood
; 120(25): 5002-13, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22821765
18.
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma.
Haematologica
; 104(2): e72-e76, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213829
19.
Circulating miRNAs as Novel Clinical Biomarkers in Temporal Lobe Epilepsy.
Noncoding RNA
; 10(2)2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525737
20.
miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.
J Cell Physiol
; 228(7): 1506-15, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23254643